Skip to main content
. 2022 Jun 14;152(8):1851–1861. doi: 10.1093/jn/nxac126

TABLE 4.

Lipoprotein variables by NMR before and after 12-wk avocado or control intervention in adults who are overweight or with obesity and have insulin resistance1

NMR analysis (variable) Avocado (n = 49) Control (n = 44) Week 12 AV vs. C, P value2 Δ0–12 wk AV vs. C, P value2
Week 0 Week 12 Δ0–12 wk Week 0 Week 12 Δ0–12 wk
Chylomicron/VLDL particle concentration, nmol/L
 Total 44.2 ± 2.73 40.7 ± 2.36 –3.90 ± 2.20 43.2 ± 2.13 42.3 ± 2.13 –0.928 ± 1.53 0.1732 0.3124
 Large 4.25 ± 0.459 4.38 ± 0.464 0.148 ± 0.299 4.06 ± 0.429 3.75 ± 0.356 –0.307 ± 0.335 0.7244 0.2090
 Medium 12.8 ± 1.23 11.7 ± 0.978 –1.16 ± 0.998 12.2 ± 1.28 11.0 ± 0.989 –1.17 ± 1.25 0.4203 0.9906
 Small 27.2 ± 2.15 24.7 ± 1.72 –2.90 ± 1.86 26.9 ± 1.50 27.5 ± 1.50 0.553 ± 1.48 0.0638 0.0797
LDL particle concentration, nmol/L
 Total 977 ± 42.3 968 ± 40.9 –1.31 ± 19.0 960 ± 36.8 1000 ± 40.0 43.5 ± 23.3 0.0694 0.0897
 IDL 250 ± 21.0 230 ± 16.9 –22.6 ± 18.0 257 ± 25.3 231 ± 17.1 –26.0 ± 20.3 0.9624 0.9498
 LDL, large 108 ± 19.1 139 ± 21.4 30.1 ± 14.3 127 ± 22.2 156 ± 21.7 29.6 ± 23.7 0.7288 0.8088
 LDL, small 619 ± 41.6 599 ± 40.0 –8.81 ± 25.9 577 ± 40.8 617 ± 41.1 39.8 ± 26.1 0.3468 0.1594
HDL particle concentration, nmol/L
 Total 32.6 ± 0.967 33.1 ± 0.943 0.408 ± 0.559 31.4 ± 0.698 31.6 ± 0.755 0.198 ± 0.459 0.8029 0.5320
 Large 6.73 ± 0.497 6.93 ± 0.510 0.177 ± 0.228 6.57 ± 0.479 6.64 ± 0.525 0.0698 ± 0.204 0.6158 0.7061
 Medium 10.9 ± 0.877 11.5 ± 0.876 0.442 ± 0.789 11.6 ± 0.749 11.9 ± 0.817 0.356 ± 0.650 0.4866 0.9114
 Small 14.9 ± 0.867 14.6 ± 0.951 –0.210 ± 0.707 13.2 ± 0.886 13.0 ± 0.977 –0.242 ± 0.739 0.4147 0.6770
Average particle size, mm
 VLDL 51.9 ± 0.958 52.4 ± 1.02 0.627 ± 0.796 50.9 ± 0.930 50.8 ± 0.889 –0.177 ± 0.731 0.3726 0.2979
 LDL 20.2 ± 0.075 20.3 ± 0.0887 0.154 ± 0.0752 20.2 ± 0.0826 20.3 ± 0.0892 0.0833 ± 0.0739 0.8590 0.6212
 HDL 9.48 ± 0.0661 9.46 ± 0.0672 <–0.00 ± 0.0333 9.47 ± 0.0757 9.45 ± 0.0706 –0.0186 ± 0.0360 0.7563 0.7553
1

Values are the unadjusted mean ± SEM of the raw data; n = 49 and 44 for the AV and C groups, respectively. AV, avocado; C, control; IDL, intermediate-density lipoprotein; GLM, general linear model.

2

ANCOVA was performed using GLM procedure via PC-SAS version 9.4 and baseline values as the covariate. Age was also included in total LDL and small LDL analyses as a significant covariate. Statistical significance was at P < 0.05. Marginal statistical effects were acknowledged at P = 0.05–0.1.